vs
CarParts.com, Inc.（PRTS）与Vericel Corp（VCEL）财务数据对比。点击上方公司名可切换其他公司
CarParts.com, Inc.的季度营收约是Vericel Corp的1.3倍（$120.4M vs $92.9M），Vericel Corp净利率更高（25.0% vs -9.6%，领先34.6%），Vericel Corp同比增速更快（23.3% vs -9.8%），过去两年Vericel Corp的营收复合增速更高（34.6% vs -8.6%）
GPC是一家总部位于美国佐治亚州亚特兰大的汽车与工业零部件分销商，1928年由弗雷泽兄弟创立，目前拥有约六万名员工。除美国本土市场外，公司业务还覆盖澳大拉西亚、比利时、加拿大、法国、德国、墨西哥、荷兰、波兰及英国，旗下拥有知名汽车零部件零售商NAPA Auto Parts和工业零部件分销商Motion。
Vericel Corp是一家美国上市生物制药企业，前身为1989年在密歇根州安娜堡成立的Aastrom Bio，2014年10月正式更为现名，专注于生物制药相关领域的研发与商业化运营。
PRTS vs VCEL — 直观对比
营收规模更大
PRTS
是对方的1.3倍
$92.9M
营收增速更快
VCEL
高出33.1%
-9.8%
净利率更高
VCEL
高出34.6%
-9.6%
两年增速更快
VCEL
近两年复合增速
-8.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $120.4M | $92.9M |
| 净利润 | $-11.6M | $23.2M |
| 毛利率 | 33.2% | 78.7% |
| 营业利润率 | — | 24.1% |
| 净利率 | -9.6% | 25.0% |
| 营收同比 | -9.8% | 23.3% |
| 净利润同比 | 25.0% | 17.3% |
| 每股收益（稀释后） | $-0.82 | $0.46 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRTSVCEL
| Q4 25 | $120.4M | $92.9M | ||
| Q3 25 | $127.8M | $67.5M | ||
| Q2 25 | $151.9M | $63.2M | ||
| Q1 25 | $147.4M | $52.6M | ||
| Q4 24 | $133.5M | $75.4M | ||
| Q3 24 | $144.8M | $57.9M | ||
| Q2 24 | $144.3M | $52.7M | ||
| Q1 24 | — | $51.3M |
净利润PRTSVCEL
| Q4 25 | $-11.6M | $23.2M | ||
| Q3 25 | $-10.9M | $5.1M | ||
| Q2 25 | $-12.7M | $-553.0K | ||
| Q1 25 | $-15.3M | $-11.2M | ||
| Q4 24 | $-15.4M | $19.8M | ||
| Q3 24 | $-10.0M | $-901.0K | ||
| Q2 24 | $-8.7M | $-4.7M | ||
| Q1 24 | — | $-3.9M |
毛利率PRTSVCEL
| Q4 25 | 33.2% | 78.7% | ||
| Q3 25 | 33.1% | 73.5% | ||
| Q2 25 | 32.8% | 73.7% | ||
| Q1 25 | 32.1% | 69.0% | ||
| Q4 24 | 32.5% | 77.6% | ||
| Q3 24 | 35.2% | 71.9% | ||
| Q2 24 | 33.5% | 69.5% | ||
| Q1 24 | — | 68.9% |
营业利润率PRTSVCEL
| Q4 25 | — | 24.1% | ||
| Q3 25 | -7.9% | 5.1% | ||
| Q2 25 | -8.2% | -3.2% | ||
| Q1 25 | -10.3% | -24.3% | ||
| Q4 24 | -11.6% | 24.5% | ||
| Q3 24 | -6.9% | -4.3% | ||
| Q2 24 | -6.0% | -11.5% | ||
| Q1 24 | — | -10.7% |
净利率PRTSVCEL
| Q4 25 | -9.6% | 25.0% | ||
| Q3 25 | -8.5% | 7.5% | ||
| Q2 25 | -8.4% | -0.9% | ||
| Q1 25 | -10.4% | -21.4% | ||
| Q4 24 | -11.5% | 26.3% | ||
| Q3 24 | -6.9% | -1.6% | ||
| Q2 24 | -6.0% | -8.9% | ||
| Q1 24 | — | -7.5% |
每股收益（稀释后）PRTSVCEL
| Q4 25 | $-0.82 | $0.46 | ||
| Q3 25 | $-0.19 | $0.10 | ||
| Q2 25 | $-0.23 | $-0.01 | ||
| Q1 25 | $-0.27 | $-0.23 | ||
| Q4 24 | $-0.28 | $0.40 | ||
| Q3 24 | $-0.17 | $-0.02 | ||
| Q2 24 | $-0.15 | $-0.10 | ||
| Q1 24 | — | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $25.8M | $137.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $53.5M | $354.6M |
| 总资产 | $184.9M | $488.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PRTSVCEL
| Q4 25 | $25.8M | $137.5M | ||
| Q3 25 | — | $135.4M | ||
| Q2 25 | — | $116.9M | ||
| Q1 25 | — | $112.9M | ||
| Q4 24 | — | $116.2M | ||
| Q3 24 | — | $101.7M | ||
| Q2 24 | — | $102.5M | ||
| Q1 24 | — | $110.6M |
股东权益PRTSVCEL
| Q4 25 | $53.5M | $354.6M | ||
| Q3 25 | $64.2M | $321.9M | ||
| Q2 25 | $62.4M | $306.8M | ||
| Q1 25 | $72.8M | $295.5M | ||
| Q4 24 | $85.2M | $292.0M | ||
| Q3 24 | $97.2M | $257.5M | ||
| Q2 24 | $103.9M | $243.0M | ||
| Q1 24 | — | $233.9M |
总资产PRTSVCEL
| Q4 25 | $184.9M | $488.0M | ||
| Q3 25 | $200.3M | $453.3M | ||
| Q2 25 | $189.6M | $435.6M | ||
| Q1 25 | $216.5M | $424.6M | ||
| Q4 24 | $210.6M | $432.7M | ||
| Q3 24 | $227.6M | $390.4M | ||
| Q2 24 | $238.0M | $376.8M | ||
| Q1 24 | — | $356.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $15.0M |
| 自由现金流经营现金流 - 资本支出 | — | $12.8M |
| 自由现金流率自由现金流/营收 | — | 13.8% |
| 资本支出强度资本支出/营收 | — | 2.4% |
| 现金转化率经营现金流/净利润 | — | 0.65× |
| 过去12个月自由现金流最近4个季度 | — | $24.7M |
8季度趋势，按日历期对齐
经营现金流PRTSVCEL
| Q4 25 | — | $15.0M | ||
| Q3 25 | $-6.4M | $22.1M | ||
| Q2 25 | $-25.6M | $8.2M | ||
| Q1 25 | $5.5M | $6.6M | ||
| Q4 24 | $1.8M | $22.2M | ||
| Q3 24 | $8.5M | $10.2M | ||
| Q2 24 | $-3.6M | $18.5M | ||
| Q1 24 | — | $7.2M |
自由现金流PRTSVCEL
| Q4 25 | — | $12.8M | ||
| Q3 25 | $-8.3M | $19.5M | ||
| Q2 25 | $-27.9M | $81.0K | ||
| Q1 25 | $3.4M | $-7.6M | ||
| Q4 24 | $-631.0K | $8.5M | ||
| Q3 24 | $4.9M | $-9.2M | ||
| Q2 24 | $-10.8M | $1.8M | ||
| Q1 24 | — | $-6.8M |
自由现金流率PRTSVCEL
| Q4 25 | — | 13.8% | ||
| Q3 25 | -6.5% | 28.8% | ||
| Q2 25 | -18.3% | 0.1% | ||
| Q1 25 | 2.3% | -14.5% | ||
| Q4 24 | -0.5% | 11.2% | ||
| Q3 24 | 3.4% | -15.9% | ||
| Q2 24 | -7.5% | 3.4% | ||
| Q1 24 | — | -13.3% |
资本支出强度PRTSVCEL
| Q4 25 | — | 2.4% | ||
| Q3 25 | 1.5% | 3.9% | ||
| Q2 25 | 1.5% | 12.9% | ||
| Q1 25 | 1.4% | 27.0% | ||
| Q4 24 | 1.8% | 18.3% | ||
| Q3 24 | 2.5% | 33.5% | ||
| Q2 24 | 4.9% | 31.8% | ||
| Q1 24 | — | 27.3% |
现金转化率PRTSVCEL
| Q4 25 | — | 0.65× | ||
| Q3 25 | — | 4.35× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.12× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRTS
暂无分部数据
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
